Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
11,273,500
-
Share change
-
+2,114,709
-
Total reported value
-
$352,077,795
-
Put/Call ratio
-
192%
-
Price per share
-
$31.23
-
Number of holders
-
95
-
Value change
-
+$51,007,586
-
Number of buys
-
63
-
Number of sells
-
52
Institutional Holders of INSYS THERAPEUTICS INC NEW - COM NEW (INSYQ) as of Q2 2014
As of 30 Jun 2014,
INSYS THERAPEUTICS INC NEW - COM NEW (INSYQ) was held by
95 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,273,500 shares.
The largest 10 holders included
JANUS CAPITAL MANAGEMENT LLC, Consonance Capital Management LP, FMR LLC, Empyrean Capital Partners, LP, BLOOM TREE PARTNERS, LLC, BlackRock Fund Advisors, VANGUARD GROUP INC, BlackRock Advisors LLC, Invesco Ltd., and BlackRock Institutional Trust Company, N.A..
This page lists
95
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.